Did you know that your browser is out of date?
For the best experience we recommend upgrading to the latest version of these supported browsers:
I wish to continue viewing on my unsupported browser
Health Care
Cost Benefit Analysis in Health Care
Cost Benefit Analysis in Health Care
Evaluating the costs and/or benefits of a public service, policy proposal, regulatory program, or the introduction of a new medicine is an integral process to health economics. Such evaluations must consider the effect on all stakeholders, any hidden costs and benefits, and the long-run risks due to a variety of outcomes.
NERA's economists have the skills and experience to undertake robust analysis to help evaluate our clients' decisions. We advise on a variety of economic evaluation themes including cost-benefit and cost effectiveness studies, outcomes assessment, analyses requiring revealed preferences or contingent evaluation framework, and damages evaluation. Our clients come from the public and private sectors.
| Name | Title | Location | Phone | |
|---|---|---|---|---|
| Dr. Subramaniam (Subbu) Ramanarayanan | Managing Director |
New York City
Los Angeles |
+1 212 345 0745
+1 213 346 3038 |
subbu.ramanarayanan@nera.com |
| Dr. Paul Wong | Director | Los Angeles | +1 213 346 3026 | paul.wong@nera.com |
| Kevin Counsell | Associate Director |
Wellington
Sydney |
+64 4 819 2551
+61 2 8864 7235 |
kevin.counsell@nera.com |
| Dr. Emily Walden | Senior Consultant | Washington, DC | +1 202 466 9220 | emily.walden@nera.com |
| Brigid Jung | Consultant | New York City | +1 212 345 7039 | brigid.jung@nera.com |
| Dr. Thomas McCarthy | Affiliated Consultant | Los Angeles | +1 213 346 3000 | thomas.mccarthy.affiliate@nera.com |
| Title | Type | Author | ||
|---|---|---|---|---|
| Non-Compete Agreements: Might They Be Procompetitive in Health Care? | Published Article | Dr. Paul Wong and Dr. Emily Walden | ||
| Drug Rebates: A Peek Behind the Curtain at Drug Prices | Published Article | Dr. Christopher Stomberg | ||
| Taking Stock of the Efficiencies Defense: Lessons from Recent Health Care Merger Revi... | Published Article | Dr. Subramaniam Ramanarayanan | ||
| Paper Trail: Review of a Recent Working Paper on the Effect of Copay Coupons on Drug ... | Published Article | Bryan Ray and Dr. Subbu Ramanarayanan | ||
| Alcohol in London: A Cost-Benefit Analysis | Report | By Michael Spackman et al. | ||
|
|
||||
| Title | Date | |||
|---|---|---|---|---|
| Intro to Health Care and Lifesciences for Antitrust Practitioners | 05 March 2020 | |||
| NERA Expert Speaks at NYSBA Executive Committee Meeting | 17 April 2019 | |||
| The ABCs of Antitrust in Healthcare: Mergers, Affiliations, and Acquisitions, Part II | 13 February 2018 | |||
| Analyzing the Outcome of the Health Insurance Mega-Mergers, Part 2: Anthem/Cigna Merg... | 21 April 2017 | |||
| Back to the Future: Hospital Merger Enforcement | 28 March 2017 | |||
| Webinar: Third Circuit's Ruling in FTC v. Hershey/Pinnacle: Game Changer or More of t... | 16 November 2016 | |||
| Reconciling Competition and Consumer Protection in Health Care | 20 September 2016 | |||
| Antitrust in Healthcare Conference | 12 May 2016 | |||
|
|
||||
| Title | Date | Type | ||
|---|---|---|---|---|
| NERA Economic Consulting Announces Senior-Level Promotions | 23 February 2021 | Press Release | ||
| NERA Economic Consulting Announces Senior-Level Promotions | 19 March 2019 | Press Release | ||
| NERA Economic Consulting Opens Office in Miami, Florida | 14 November 2017 | Press Release | ||
| NERA Experts Honored with 2017 Antitrust Writing Award | 31 March 2017 | Press Release | ||
| NERA Economic Consulting Recognized in Who’s Who Legal: Consulting Experts Guide | 06 October 2016 | Press Release | ||
| Integrated care with fragmented teams | 23 May 2016 | Media Coverage | ||
|
|
||||